Intensive Music Therapy on Cognitive Function in Subacute Stroke Rehabilitation in Malaysia

Launched by UNIVERSITY OF MALAYA · Jan 7, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at whether intensive music therapy can help improve thinking skills, like memory and attention, in stroke patients who are in rehabilitation. The study aims to see how well this type of therapy works and if it can fit into the usual treatments that stroke patients receive. By testing this approach, the researchers hope to gather information that can lead to a larger study in the future.

To participate in this trial, individuals need to be between 18 and 75 years old and have had a stroke within the last three months, confirmed by a medical scan. They should also have mild to moderate cognitive difficulties, which means they might have trouble with thinking tasks but can still communicate and follow instructions. However, those with severe speech problems, significant hearing or vision issues that affect their ability to engage in music therapy, or other serious health conditions will not be eligible. Participants can expect to take part in music therapy sessions designed to help them regain cognitive functions while also contributing to important research that could benefit future stroke recovery treatments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosed with ischemic or haemorrhagic stroke confirmed by CT scan
• • Duration of stroke within the first 3 months
• • Aged 18 - 75 years old
• • Ability to provide informed consent
• • Understands Bahasa Melayu or English with basic communication abilities to follow instructions during therapy sessions
• • Mild to moderate cognitive impairments with MoCA score of 10-25.
• Exclusion Criteria:
• • Severe aphasia
• • Significant uncorrected hearing or visual impairments preventing engagement in music therapy.
• • Severe or unstable medical conditions (e.g., uncontrolled hypertension or diabetes).
• • Medications that significantly impair cognition or motor function (e.g., high dose sedatives).
• • History of neurological diseases other than stroke (eg, Parkinson's disease).